Covid-19 affects penile function
Nakita.id – Case Covid-19 according to the latest government data on Thursday (13/5/2021) there were an increase of 3,448 people.
This means total cases Covid-19 in Indonesia since it was first announced on March 2, namely 1,731,652.
One way to reduce the spread Covid-19 is doing vaccinations.
But there is something more important for men and dads.
Experts suspect the Covid-19 virus can interfere with men’s ability in bed.
How can? Covid-19 infection is known to damage blood vessels, including those that supply blood to the penis organs.
Research using an electron microscope showed the presence of coronavirus particles in penile tissue samples from two men who had been infected Covid-19 and suffer impotence after recovering.
As quoted from Kompas.com, the two men were infected with Covid-19 about 8 months earlier.
Meanwhile, other research says there is evidence of damage to blood vessels in the penis in Covid-19 patients compared to men who also suffer from erectile dysfunction but have never been infected with the coronavirus.
“We found that the virus affects the blood vessels that supply part of the penis, causing erectile dysfunction,” said senior researcher Dr. Ranjith Ramasamy, director of the urology health program.
Ramasamy continued, the blood vessels malfunctioned and were unable to provide sufficient blood to the penis for an erection.
He then compared the organ damage to that of the lungs, kidneys and brain in Covid-19 patients.
“The penis is also affected just like other internal organs. It looks like this effect can be permanent,” he said.
Meanwhile, the number of people who have had the second dose of Covid-19 vaccine in Indonesia has so far reached 8,919,557 people.
This was conveyed by the government on Thursday (13/5/2021).
Then, the number of people who had the first dose of Covid-19 vaccine was 13,695,553 people.
On the other hand, people who have been vaccinated are health workers, public officials, and the elderly.
Vaccine Covid-19 help achieve herd immunity against diseases caused by the SARS-CoV-2 virus.